We transform patient care with autonomous blood drawing technology
Access to care depends on scarcely available healthcare workers. We reinvent clinical procedures to reduce their workload, helping to build a scalable, future-proof system.
Introducing the new standard in blood drawing
Vitestro will be the first to bring autonomous blood drawing technology to European hospitals. Blood drawing, performed billions of times per year worldwide, is key to clinical diagnosis. Given the mounting shortages of healthcare personnel, there is a clear need for a future-proof system to guarantee continuity of care.
The Product
Vitestro's device combines AI-based, ultrasound-guided 3D reconstruction with robotic needle insertion, ensuring accurate and secure blood collection . The procedure is performed fully automatically, from tourniquet to bandage application.
The cornerstone of our approach is an empathic, intuitive and efficient patient experience. The device can be used under supervision by patients of 16 years and older, including those with comorbidities and/or difficult venous access.
Clinical development with R&D partners
Vitestro performs its clinical development activities together with leading European hospitals and laboratories. Automated blood drawing studies have been conducted with healthy volunteers and patients of all ages since 2020.
'More than 1000 patients participated in clinical trials, multiple hospitals participated '
- Toon Overbeeke, CEO Vitestro
'By introducing automated blood drawing, high quality, as well as capacity, is guaranteed in our laboratories.’
- Anja Leyte, Director OLVG Laboratories
'Vitestro's technology helps improving sample standardization and solving staffing shortages at our blood drawing department. Patients are also very positive.'
- Anja Leyte, Director OVLG Laboratories
'Automated blood drawing will play a key role in the future of laboratory medicine. I can't wait to see the first devices working in our labs.'
- François Verheijen, Clinical Chemist, Result Laboratorium, NL
'It is great to see, during clinical testing, how the device can make a difference for patients.'
- Luuk Giesen, Medical Officer Vitestro
Increasing access to diagnostics
The introduction of Vitestro’s autonomous blood drawing devices increases access to laboratory diagnostics for patients. Continuous operation boosts the availability of blood drawing services, empowering patients to go for a blood draw on their own schedule.
Collaborating with leading hospitals
Vitestro is thrilled to receive extensive support from leading hospitals and clinical laboratories across Europe. Together we will realize a future where our autonomous device has become the standard, transforming patient care for millions of people.
Patient First
The company goals is to provide a high level of patient safety and to reduce anxiety in the blood drawing experience. By standardizing the vast part of the procedure, the device reduces dependency on personnel and increases standardization and quality of the blood drawing procedure.
NEWS
+
-
Vitestro raises EUR 12 million in Series A financing round to bring the world's first autonomous blood drawing device to the European market
Vitestro, developer of an autonomous blood drawing device, announces the completion of a Series A financing round. California-based Sonder Capital led the funding round alongside existing investors.
Vitestro haalt 12 miljoen euro op richting marktintroductie van 's werelds eerste autonome bloedafnameapparaat
Vitestro, ontwikkelaar van een autonoom bloedafnameapparaat, heeft een Serie A-financieringsronde afgerond. Het in Californië gevestigde Sonder Capital leidde de ronde.
Vitestro is proud to have received a grant from REACT-EU, provided by the European Regional Development Fund (EFRD). The REACT-EU programme (Recovery Assistance for Cohesion and the Territories of Europe).
The idea for Vitestro was conceived when Toon and Brian, entrepreneurs and business partners for many years, were discussing frustrations about the availability of care for their loved ones. In Toon's case, a friend's father was very difficult to puncture due to chemotherapy, while Brian's experienced long waiting times and logistic errors when one of his kids needed regular blood checkups.
These personal experiences led to discussions about the cornerstone of good patient care: blood analysis. Together the founders saw an opportunity to improve patient care with autonomous phlebotomy. They decided to start on an adventure together…
Teaming with experts
A few years later, Vitestro’s multi-disciplinary team, with the help of laboratories, hospitals and many other partners is well on their way to transforming patient care globally with the introduction of this innovation. 35+ colleagues joined Vitestro’s mission in the past 5 years. Do you also thrive on great challenges? Check out our careers page.
